Abstract

Objectives National estimates of healthcare expenditures by types of services for adults with comorbid diabetes and eye complications (ECs) are scarce. Therefore, the first objective of this study is to estimate total healthcare expenditures and expenditures by types of services (inpatient, outpatient, prescription, and emergency) for adults with ECs. The second objective is to estimate the out-of-pocket spending burden among adults with ECs. Study Design. A cross-sectional study design using data from multiple panels (2009-2015) of the Medical Expenditure Panel Survey was employed. The sample included adults aged 21 years or older with diabetes (n = 8,420). Principal Findings. Of adults with diabetes, 18.9% had ECs. Adults ECs had significantly higher incremental total medical expenditures of $3,125. The highest incremental expenditures were associated with outpatient and prescription drugs. After controlling for sex, age, race, poverty level, insurance coverage, prescription coverage, perceived physical and mental health, the number of chronic physical and mental conditions, marital status, education, the region of residence, smoking status, exercise, and chronic kidney disease (CKD), there was no difference in the out-of-pocket spending burden between adults with and those without ECs. However, adults with comorbid diabetes and CKD were more likely to have the out-of-pocket spending burden than those without CKD. Conclusions The study showed that ECs in individuals with diabetes are associated with high incremental direct medical and out-of-pocket expenditures. Therefore, it requires more health initiatives, interventions, strategies, and programs to address and minimize the risk involved in such affected individuals.

Highlights

  • Diabetes, a metabolic disorder, impairs health-related quality of life (HRQoL) and exerts a substantial socioeconomic burden, on the individuals and on the family and the society at large

  • Around 19% of adults with diabetes had eye complications (ECs) between 1999 and 2006 [4], and about 4% of adults aged above 40 years with diabetes had advanced diabetic retinopathy associated with macular edema and proliferative diabetic retinopathy that resulted in severe vision loss

  • The study used the Medical Expenditure Panel Survey (MEPS) to estimate the incremental direct medical expenditures associated with ECs among adults with diabetes in the United States of America (US)

Read more

Summary

Introduction

A metabolic disorder, impairs health-related quality of life (HRQoL) and exerts a substantial socioeconomic burden, on the individuals and on the family and the society at large. Around 19% of adults with diabetes had eye complications (ECs) between 1999 and 2006 [4], and about 4% of adults aged above 40 years with diabetes had advanced diabetic retinopathy associated with macular edema and proliferative diabetic retinopathy that resulted in severe vision loss. Diabetic eye complications are the prime cause for vision loss, and according to two population-based studies, 2.6 million people were visually impaired because of diabetes in 2015, and it is projected to rise to 3.2 million in 2020 [5, 6]. The financial burden of diabetes-related ECs is found to be high among adults in the US, those with any degree of the eye or renal complications [7]. The increased direct medical expenditures associated with ECs impose an economic burden on both individuals and payers

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call